Brazil Newborn Screening Market Size & Outlook, 2023-2030
Brazil newborn screening market, 2018-2030 (US$M)
Related Markets
Brazil newborn screening market highlights
- The Brazil newborn screening market generated a revenue of USD 17.3 million in 2023 and is expected to reach USD 26.0 million by 2030.
- The Brazil market is expected to grow at a CAGR of 6% from 2024 to 2030.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
Newborn screening market data book summary
| Market revenue in 2023 | USD 17.3 million |
| Market revenue in 2030 | USD 26.0 million |
| Growth rate | 6% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.2% of the global newborn screening market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Mexico newborn screening market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 27.4 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.86% in 2023. Horizon Databook has segmented the Brazil newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
Federal law for the Newborn Screening National Program (NSNP) was implemented in 2001, making it mandatory for all hospitals and clinics. About 80% of population is covered and undergoes these tests. The conditions screened include phenylketonuria and congenital hypothyroidism. Ten of the 27 states of Brazil additionally test for sickle cell disease and hemoglobinopathies.
Brazil has over 237 screening centers for hearing loss, making it the largest in Latin America. These centers were established by the combined efforts of The Brazilian Society of Otalaryngology, The Brazilian Society of Speech Pathology, The Brazilian Society of Pediatrics, and other national level institutions.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil newborn screening market size, by technology, 2018-2030 (US$M)
Brazil Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
